Healthtech Solutions Inc.
Healthtech Solutions Inc. (HLTT) Stock Competitors & Peer Comparison
See (HLTT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HLTT | $0.00 | +0.00% | 10.7K | N/A | -$0.04 | N/A |
| BNVIF | $0.10 | +99900.00% | 169B | -0.16 | -$0.63 | N/A |
| PMCUF | $205.00 | -4.34% | 21.4B | 336.07 | $0.61 | +0.14% |
| CNONF | $0.04 | +389900.00% | 19.5B | -0.26 | -$0.15 | N/A |
| MTHRF | $12.98 | -0.31% | 8.8B | 32.45 | $0.40 | +1.08% |
| MTHRY | $6.36 | +2.75% | 8.5B | 31.43 | $0.20 | N/A |
| PANHF | $1.40 | +42.74% | 3B | 140.00 | $0.01 | +89.04% |
| PIAHY | $2.30 | -11.54% | 1.2B | 115.00 | $0.02 | +216.14% |
| CMPVF | $23.75 | -0.44% | 1.2B | 40.95 | $0.58 | +4.93% |
| RSLBF | $35.80 | -2.85% | 1.2B | 53.43 | $0.67 | +0.88% |
Stock Comparison
HLTT vs BNVIF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, BNVIF has a market cap of 169B. Regarding current trading prices, HLTT is priced at $0.00, while BNVIF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas BNVIF's P/E ratio is -0.16. In terms of profitability, HLTT's ROE is +1789941.38%, compared to BNVIF's ROE of -4.34%. Regarding short-term risk, HLTT is less volatile compared to BNVIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check BNVIF's competition here
HLTT vs PMCUF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PMCUF has a market cap of 21.4B. Regarding current trading prices, HLTT is priced at $0.00, while PMCUF trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PMCUF's P/E ratio is 336.07. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PMCUF's ROE of +0.48%. Regarding short-term risk, HLTT is less volatile compared to PMCUF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check PMCUF's competition here
HLTT vs CNONF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CNONF has a market cap of 19.5B. Regarding current trading prices, HLTT is priced at $0.00, while CNONF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CNONF's P/E ratio is -0.26. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CNONF's ROE of +1.60%. Regarding short-term risk, HLTT is less volatile compared to CNONF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check CNONF's competition here
HLTT vs MTHRF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MTHRF has a market cap of 8.8B. Regarding current trading prices, HLTT is priced at $0.00, while MTHRF trades at $12.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MTHRF's P/E ratio is 32.45. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MTHRF's ROE of +0.11%. Regarding short-term risk, HLTT is less volatile compared to MTHRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MTHRF's competition here
HLTT vs MTHRY Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MTHRY has a market cap of 8.5B. Regarding current trading prices, HLTT is priced at $0.00, while MTHRY trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MTHRY's P/E ratio is 31.43. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MTHRY's ROE of +0.11%. Regarding short-term risk, HLTT is less volatile compared to MTHRY. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MTHRY's competition here
HLTT vs PANHF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PANHF has a market cap of 3B. Regarding current trading prices, HLTT is priced at $0.00, while PANHF trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PANHF's P/E ratio is 140.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PANHF's ROE of -0.00%. Regarding short-term risk, HLTT and PANHF have similar daily volatility (0.00).Check PANHF's competition here
HLTT vs PIAHY Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PIAHY has a market cap of 1.2B. Regarding current trading prices, HLTT is priced at $0.00, while PIAHY trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PIAHY's P/E ratio is 115.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PIAHY's ROE of -0.00%. Regarding short-term risk, HLTT is less volatile compared to PIAHY. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check PIAHY's competition here
HLTT vs CMPVF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CMPVF has a market cap of 1.2B. Regarding current trading prices, HLTT is priced at $0.00, while CMPVF trades at $23.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CMPVF's P/E ratio is 40.95. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CMPVF's ROE of +0.04%. Regarding short-term risk, HLTT and CMPVF have similar daily volatility (0.00).Check CMPVF's competition here
HLTT vs RSLBF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, RSLBF has a market cap of 1.2B. Regarding current trading prices, HLTT is priced at $0.00, while RSLBF trades at $35.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas RSLBF's P/E ratio is 53.43. In terms of profitability, HLTT's ROE is +1789941.38%, compared to RSLBF's ROE of +0.26%. Regarding short-term risk, HLTT and RSLBF have similar daily volatility (0.00).Check RSLBF's competition here
HLTT vs CMPUY Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CMPUY has a market cap of 1.2B. Regarding current trading prices, HLTT is priced at $0.00, while CMPUY trades at $23.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CMPUY's P/E ratio is 38.98. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CMPUY's ROE of +0.04%. Regarding short-term risk, HLTT and CMPUY have similar daily volatility (0.00).Check CMPUY's competition here
HLTT vs CRWRF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CRWRF has a market cap of 956.7M. Regarding current trading prices, HLTT is priced at $0.00, while CRWRF trades at $27.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CRWRF's P/E ratio is 65.05. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CRWRF's ROE of +0.04%. Regarding short-term risk, HLTT is less volatile compared to CRWRF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check CRWRF's competition here
HLTT vs SMSZF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, SMSZF has a market cap of 849.5M. Regarding current trading prices, HLTT is priced at $0.00, while SMSZF trades at $10.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas SMSZF's P/E ratio is 21.48. In terms of profitability, HLTT's ROE is +1789941.38%, compared to SMSZF's ROE of +0.13%. Regarding short-term risk, HLTT and SMSZF have similar daily volatility (0.00).Check SMSZF's competition here
HLTT vs SUSRF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, SUSRF has a market cap of 790.9M. Regarding current trading prices, HLTT is priced at $0.00, while SUSRF trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas SUSRF's P/E ratio is 55.36. In terms of profitability, HLTT's ROE is +1789941.38%, compared to SUSRF's ROE of +0.03%. Regarding short-term risk, HLTT and SUSRF have similar daily volatility (0.00).Check SUSRF's competition here
HLTT vs VHIBF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, VHIBF has a market cap of 556.9M. Regarding current trading prices, HLTT is priced at $0.00, while VHIBF trades at $10.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas VHIBF's P/E ratio is 337.33. In terms of profitability, HLTT's ROE is +1789941.38%, compared to VHIBF's ROE of +0.02%. Regarding short-term risk, HLTT and VHIBF have similar daily volatility (0.00).Check VHIBF's competition here
HLTT vs KSIOF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, KSIOF has a market cap of 392.4M. Regarding current trading prices, HLTT is priced at $0.00, while KSIOF trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas KSIOF's P/E ratio is -206.50. In terms of profitability, HLTT's ROE is +1789941.38%, compared to KSIOF's ROE of -0.05%. Regarding short-term risk, HLTT is less volatile compared to KSIOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check KSIOF's competition here
HLTT vs ACMLF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ACMLF has a market cap of 317.5M. Regarding current trading prices, HLTT is priced at $0.00, while ACMLF trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ACMLF's P/E ratio is 73.67. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ACMLF's ROE of +0.21%. Regarding short-term risk, HLTT is less volatile compared to ACMLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check ACMLF's competition here
HLTT vs ONVVF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ONVVF has a market cap of 303.2M. Regarding current trading prices, HLTT is priced at $0.00, while ONVVF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ONVVF's P/E ratio is -20.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ONVVF's ROE of -0.97%. Regarding short-term risk, HLTT is less volatile compared to ONVVF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check ONVVF's competition here
HLTT vs SMDCF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, SMDCF has a market cap of 280.9M. Regarding current trading prices, HLTT is priced at $0.00, while SMDCF trades at $17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas SMDCF's P/E ratio is -17.32. In terms of profitability, HLTT's ROE is +1789941.38%, compared to SMDCF's ROE of N/A. Regarding short-term risk, HLTT and SMDCF have similar daily volatility (0.00).Check SMDCF's competition here
HLTT vs DLHTF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, DLHTF has a market cap of 254.8M. Regarding current trading prices, HLTT is priced at $0.00, while DLHTF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas DLHTF's P/E ratio is -17.24. In terms of profitability, HLTT's ROE is +1789941.38%, compared to DLHTF's ROE of -0.24%. Regarding short-term risk, HLTT and DLHTF have similar daily volatility (0.00).Check DLHTF's competition here
HLTT vs VPAHF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, VPAHF has a market cap of 188.2M. Regarding current trading prices, HLTT is priced at $0.00, while VPAHF trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas VPAHF's P/E ratio is -37.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to VPAHF's ROE of -0.18%. Regarding short-term risk, HLTT and VPAHF have similar daily volatility (0.00).Check VPAHF's competition here
HLTT vs COGZF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, COGZF has a market cap of 183.4M. Regarding current trading prices, HLTT is priced at $0.00, while COGZF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas COGZF's P/E ratio is 27.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to COGZF's ROE of +0.17%. Regarding short-term risk, HLTT is less volatile compared to COGZF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check COGZF's competition here
HLTT vs CSAMF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CSAMF has a market cap of 98.8M. Regarding current trading prices, HLTT is priced at $0.00, while CSAMF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CSAMF's P/E ratio is -9.64. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CSAMF's ROE of -1.57%. Regarding short-term risk, HLTT and CSAMF have similar daily volatility (0.00).Check CSAMF's competition here
HLTT vs HSCHF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, HSCHF has a market cap of 95M. Regarding current trading prices, HLTT is priced at $0.00, while HSCHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas HSCHF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to HSCHF's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to HSCHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check HSCHF's competition here
HLTT vs MDPEF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MDPEF has a market cap of 85.8M. Regarding current trading prices, HLTT is priced at $0.00, while MDPEF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MDPEF's P/E ratio is 8.40. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MDPEF's ROE of N/A. Regarding short-term risk, HLTT is less volatile compared to MDPEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MDPEF's competition here
HLTT vs HITC Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, HITC has a market cap of 52.8M. Regarding current trading prices, HLTT is priced at $0.00, while HITC trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas HITC's P/E ratio is -14.75. In terms of profitability, HLTT's ROE is +1789941.38%, compared to HITC's ROE of -0.84%. Regarding short-term risk, HLTT is less volatile compared to HITC. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check HITC's competition here
HLTT vs RQHTF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, RQHTF has a market cap of 45M. Regarding current trading prices, HLTT is priced at $0.00, while RQHTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas RQHTF's P/E ratio is -0.10. In terms of profitability, HLTT's ROE is +1789941.38%, compared to RQHTF's ROE of -2.22%. Regarding short-term risk, HLTT and RQHTF have similar daily volatility (0.00).Check RQHTF's competition here
HLTT vs TREIF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, TREIF has a market cap of 29.1M. Regarding current trading prices, HLTT is priced at $0.00, while TREIF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas TREIF's P/E ratio is -2.75. In terms of profitability, HLTT's ROE is +1789941.38%, compared to TREIF's ROE of -9.28%. Regarding short-term risk, HLTT and TREIF have similar daily volatility (0.00).Check TREIF's competition here
HLTT vs AHGIF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, AHGIF has a market cap of 27.3M. Regarding current trading prices, HLTT is priced at $0.00, while AHGIF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas AHGIF's P/E ratio is -1.52. In terms of profitability, HLTT's ROE is +1789941.38%, compared to AHGIF's ROE of -2.79%. Regarding short-term risk, HLTT is less volatile compared to AHGIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check AHGIF's competition here
HLTT vs RTNXF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, RTNXF has a market cap of 22.5M. Regarding current trading prices, HLTT is priced at $0.00, while RTNXF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas RTNXF's P/E ratio is -0.33. In terms of profitability, HLTT's ROE is +1789941.38%, compared to RTNXF's ROE of +1.94%. Regarding short-term risk, HLTT is less volatile compared to RTNXF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check RTNXF's competition here
HLTT vs HDSLF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, HDSLF has a market cap of 21.1M. Regarding current trading prices, HLTT is priced at $0.00, while HDSLF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas HDSLF's P/E ratio is -3.22. In terms of profitability, HLTT's ROE is +1789941.38%, compared to HDSLF's ROE of -1.31%. Regarding short-term risk, HLTT is less volatile compared to HDSLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check HDSLF's competition here
HLTT vs VASO Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, VASO has a market cap of 21.1M. Regarding current trading prices, HLTT is priced at $0.00, while VASO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas VASO's P/E ratio is 12.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to VASO's ROE of +0.04%. Regarding short-term risk, HLTT is less volatile compared to VASO. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check VASO's competition here
HLTT vs DGNOF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, DGNOF has a market cap of 18.3M. Regarding current trading prices, HLTT is priced at $0.00, while DGNOF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas DGNOF's P/E ratio is -4.50. In terms of profitability, HLTT's ROE is +1789941.38%, compared to DGNOF's ROE of +4.77%. Regarding short-term risk, HLTT is less volatile compared to DGNOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check DGNOF's competition here
HLTT vs THKKF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, THKKF has a market cap of 17.8M. Regarding current trading prices, HLTT is priced at $0.00, while THKKF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas THKKF's P/E ratio is -1.51. In terms of profitability, HLTT's ROE is +1789941.38%, compared to THKKF's ROE of -0.61%. Regarding short-term risk, HLTT and THKKF have similar daily volatility (0.00).Check THKKF's competition here
HLTT vs RYAHF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, RYAHF has a market cap of 16M. Regarding current trading prices, HLTT is priced at $0.00, while RYAHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas RYAHF's P/E ratio is 0.81. In terms of profitability, HLTT's ROE is +1789941.38%, compared to RYAHF's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to RYAHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check RYAHF's competition here
HLTT vs MNNDF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MNNDF has a market cap of 14.3M. Regarding current trading prices, HLTT is priced at $0.00, while MNNDF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MNNDF's P/E ratio is -1.48. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MNNDF's ROE of N/A. Regarding short-term risk, HLTT is less volatile compared to MNNDF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MNNDF's competition here
HLTT vs PBSV Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PBSV has a market cap of 13.8M. Regarding current trading prices, HLTT is priced at $0.00, while PBSV trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PBSV's P/E ratio is -60.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PBSV's ROE of -0.00%. Regarding short-term risk, HLTT and PBSV have similar daily volatility (0.00).Check PBSV's competition here
HLTT vs UDOCF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, UDOCF has a market cap of 12M. Regarding current trading prices, HLTT is priced at $0.00, while UDOCF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas UDOCF's P/E ratio is -2.62. In terms of profitability, HLTT's ROE is +1789941.38%, compared to UDOCF's ROE of +6.57%. Regarding short-term risk, HLTT is less volatile compared to UDOCF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check UDOCF's competition here
HLTT vs CRVW Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CRVW has a market cap of 11.3M. Regarding current trading prices, HLTT is priced at $0.00, while CRVW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CRVW's P/E ratio is -1.93. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CRVW's ROE of +0.16%. Regarding short-term risk, HLTT is less volatile compared to CRVW. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check CRVW's competition here
HLTT vs SPLTF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, SPLTF has a market cap of 10.2M. Regarding current trading prices, HLTT is priced at $0.00, while SPLTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas SPLTF's P/E ratio is -3.33. In terms of profitability, HLTT's ROE is +1789941.38%, compared to SPLTF's ROE of -6.63%. Regarding short-term risk, HLTT and SPLTF have similar daily volatility (0.00).Check SPLTF's competition here
HLTT vs CMHSF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CMHSF has a market cap of 10.1M. Regarding current trading prices, HLTT is priced at $0.00, while CMHSF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CMHSF's P/E ratio is 3.11. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CMHSF's ROE of +0.10%. Regarding short-term risk, HLTT is less volatile compared to CMHSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check CMHSF's competition here
HLTT vs EMOR Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, EMOR has a market cap of 9.8M. Regarding current trading prices, HLTT is priced at $0.00, while EMOR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas EMOR's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to EMOR's ROE of +0.28%. Regarding short-term risk, HLTT and EMOR have similar daily volatility (0.00).Check EMOR's competition here
HLTT vs CDXFF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CDXFF has a market cap of 9.7M. Regarding current trading prices, HLTT is priced at $0.00, while CDXFF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CDXFF's P/E ratio is -1.35. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CDXFF's ROE of +0.44%. Regarding short-term risk, HLTT and CDXFF have similar daily volatility (0.00).Check CDXFF's competition here
HLTT vs VYND Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, VYND has a market cap of 9.2M. Regarding current trading prices, HLTT is priced at $0.00, while VYND trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas VYND's P/E ratio is -49.99. In terms of profitability, HLTT's ROE is +1789941.38%, compared to VYND's ROE of +0.48%. Regarding short-term risk, HLTT and VYND have similar daily volatility (0.00).Check VYND's competition here
HLTT vs HBCNF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, HBCNF has a market cap of 8.4M. Regarding current trading prices, HLTT is priced at $0.00, while HBCNF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas HBCNF's P/E ratio is -0.59. In terms of profitability, HLTT's ROE is +1789941.38%, compared to HBCNF's ROE of -0.57%. Regarding short-term risk, HLTT is less volatile compared to HBCNF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check HBCNF's competition here
HLTT vs CRBKF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CRBKF has a market cap of 6.8M. Regarding current trading prices, HLTT is priced at $0.00, while CRBKF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CRBKF's P/E ratio is -1.40. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CRBKF's ROE of +68.80%. Regarding short-term risk, HLTT and CRBKF have similar daily volatility (0.00).Check CRBKF's competition here
HLTT vs DOCRF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, DOCRF has a market cap of 6.2M. Regarding current trading prices, HLTT is priced at $0.00, while DOCRF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas DOCRF's P/E ratio is -0.11. In terms of profitability, HLTT's ROE is +1789941.38%, compared to DOCRF's ROE of -2.21%. Regarding short-term risk, HLTT and DOCRF have similar daily volatility (0.00).Check DOCRF's competition here
HLTT vs AIMLF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, AIMLF has a market cap of 5.5M. Regarding current trading prices, HLTT is priced at $0.00, while AIMLF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas AIMLF's P/E ratio is -0.79. In terms of profitability, HLTT's ROE is +1789941.38%, compared to AIMLF's ROE of -11.81%. Regarding short-term risk, HLTT and AIMLF have similar daily volatility (0.00).Check AIMLF's competition here
HLTT vs CMPD Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CMPD has a market cap of 5M. Regarding current trading prices, HLTT is priced at $0.00, while CMPD trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CMPD's P/E ratio is -14.78. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CMPD's ROE of +0.07%. Regarding short-term risk, HLTT and CMPD have similar daily volatility (0.00).Check CMPD's competition here
HLTT vs CBDS Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CBDS has a market cap of 4.3M. Regarding current trading prices, HLTT is priced at $0.00, while CBDS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CBDS's P/E ratio is -1.49. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CBDS's ROE of +1.55%. Regarding short-term risk, HLTT is less volatile compared to CBDS. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check CBDS's competition here
HLTT vs IQAIF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, IQAIF has a market cap of 4.2M. Regarding current trading prices, HLTT is priced at $0.00, while IQAIF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas IQAIF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to IQAIF's ROE of -1.62%. Regarding short-term risk, HLTT and IQAIF have similar daily volatility (0.00).Check IQAIF's competition here
HLTT vs EBYH Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, EBYH has a market cap of 2.1M. Regarding current trading prices, HLTT is priced at $0.00, while EBYH trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas EBYH's P/E ratio is -6.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to EBYH's ROE of -0.03%. Regarding short-term risk, HLTT and EBYH have similar daily volatility (0.00).Check EBYH's competition here
HLTT vs EWLL Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, EWLL has a market cap of 1.9M. Regarding current trading prices, HLTT is priced at $0.00, while EWLL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas EWLL's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to EWLL's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to EWLL. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check EWLL's competition here
HLTT vs MITI Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MITI has a market cap of 1.8M. Regarding current trading prices, HLTT is priced at $0.00, while MITI trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MITI's P/E ratio is -5.33. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MITI's ROE of -0.05%. Regarding short-term risk, HLTT is less volatile compared to MITI. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MITI's competition here
HLTT vs ICCO Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ICCO has a market cap of 1.8M. Regarding current trading prices, HLTT is priced at $0.00, while ICCO trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ICCO's P/E ratio is -9.82. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ICCO's ROE of +0.17%. Regarding short-term risk, HLTT is less volatile compared to ICCO. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check ICCO's competition here
HLTT vs CTVEF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CTVEF has a market cap of 1.2M. Regarding current trading prices, HLTT is priced at $0.00, while CTVEF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CTVEF's P/E ratio is -0.16. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CTVEF's ROE of +0.08%. Regarding short-term risk, HLTT is less volatile compared to CTVEF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check CTVEF's competition here
HLTT vs DTRK Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, DTRK has a market cap of 1M. Regarding current trading prices, HLTT is priced at $0.00, while DTRK trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas DTRK's P/E ratio is -4.71. In terms of profitability, HLTT's ROE is +1789941.38%, compared to DTRK's ROE of -9.79%. Regarding short-term risk, HLTT and DTRK have similar daily volatility (0.00).Check DTRK's competition here
HLTT vs LVCE Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, LVCE has a market cap of 923.9K. Regarding current trading prices, HLTT is priced at $0.00, while LVCE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas LVCE's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to LVCE's ROE of N/A. Regarding short-term risk, HLTT and LVCE have similar daily volatility (0.00).Check LVCE's competition here
HLTT vs PPJE Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PPJE has a market cap of 920.5K. Regarding current trading prices, HLTT is priced at $0.00, while PPJE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PPJE's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PPJE's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to PPJE. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check PPJE's competition here
HLTT vs MDBIF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MDBIF has a market cap of 867.8K. Regarding current trading prices, HLTT is priced at $0.00, while MDBIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MDBIF's P/E ratio is -0.14. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MDBIF's ROE of -0.14%. Regarding short-term risk, HLTT is less volatile compared to MDBIF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MDBIF's competition here
HLTT vs CSOC Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CSOC has a market cap of 774.8K. Regarding current trading prices, HLTT is priced at $0.00, while CSOC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CSOC's P/E ratio is 0.14. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CSOC's ROE of -2.38%. Regarding short-term risk, HLTT and CSOC have similar daily volatility (0.00).Check CSOC's competition here
HLTT vs MDXL Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MDXL has a market cap of 677.8K. Regarding current trading prices, HLTT is priced at $0.00, while MDXL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MDXL's P/E ratio is -0.08. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MDXL's ROE of +0.13%. Regarding short-term risk, HLTT and MDXL have similar daily volatility (0.00).Check MDXL's competition here
HLTT vs EKGGF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, EKGGF has a market cap of 675.8K. Regarding current trading prices, HLTT is priced at $0.00, while EKGGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas EKGGF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to EKGGF's ROE of +0.81%. Regarding short-term risk, HLTT and EKGGF have similar daily volatility (0.00).Check EKGGF's competition here
HLTT vs TSTTF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, TSTTF has a market cap of 665.8K. Regarding current trading prices, HLTT is priced at $0.00, while TSTTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas TSTTF's P/E ratio is -3.33. In terms of profitability, HLTT's ROE is +1789941.38%, compared to TSTTF's ROE of +0.12%. Regarding short-term risk, HLTT and TSTTF have similar daily volatility (0.00).Check TSTTF's competition here
HLTT vs NEWUF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, NEWUF has a market cap of 625.3K. Regarding current trading prices, HLTT is priced at $0.00, while NEWUF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas NEWUF's P/E ratio is -0.04. In terms of profitability, HLTT's ROE is +1789941.38%, compared to NEWUF's ROE of +0.67%. Regarding short-term risk, HLTT and NEWUF have similar daily volatility (0.00).Check NEWUF's competition here
HLTT vs MDNWF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MDNWF has a market cap of 517.3K. Regarding current trading prices, HLTT is priced at $0.00, while MDNWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MDNWF's P/E ratio is -0.02. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MDNWF's ROE of -1.53%. Regarding short-term risk, HLTT is less volatile compared to MDNWF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MDNWF's competition here
HLTT vs MDRM Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MDRM has a market cap of 471.9K. Regarding current trading prices, HLTT is priced at $0.00, while MDRM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MDRM's P/E ratio is -0.37. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MDRM's ROE of +0.42%. Regarding short-term risk, HLTT is less volatile compared to MDRM. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check MDRM's competition here
HLTT vs NDATF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, NDATF has a market cap of 450.5K. Regarding current trading prices, HLTT is priced at $0.00, while NDATF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas NDATF's P/E ratio is -1.09. In terms of profitability, HLTT's ROE is +1789941.38%, compared to NDATF's ROE of -0.62%. Regarding short-term risk, HLTT and NDATF have similar daily volatility (0.00).Check NDATF's competition here
HLTT vs EVAHF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, EVAHF has a market cap of 413.6K. Regarding current trading prices, HLTT is priced at $0.00, while EVAHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas EVAHF's P/E ratio is -1.19. In terms of profitability, HLTT's ROE is +1789941.38%, compared to EVAHF's ROE of +0.28%. Regarding short-term risk, HLTT is less volatile compared to EVAHF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check EVAHF's competition here
HLTT vs ACHKF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ACHKF has a market cap of 377.4K. Regarding current trading prices, HLTT is priced at $0.00, while ACHKF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ACHKF's P/E ratio is -0.05. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ACHKF's ROE of +2.16%. Regarding short-term risk, HLTT and ACHKF have similar daily volatility (0.00).Check ACHKF's competition here
HLTT vs NHIQ Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, NHIQ has a market cap of 329.7K. Regarding current trading prices, HLTT is priced at $0.00, while NHIQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas NHIQ's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to NHIQ's ROE of +0.35%. Regarding short-term risk, HLTT is less volatile compared to NHIQ. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check NHIQ's competition here
HLTT vs LFCOF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, LFCOF has a market cap of 313.3K. Regarding current trading prices, HLTT is priced at $0.00, while LFCOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas LFCOF's P/E ratio is -0.05. In terms of profitability, HLTT's ROE is +1789941.38%, compared to LFCOF's ROE of +8.70%. Regarding short-term risk, HLTT is less volatile compared to LFCOF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check LFCOF's competition here
HLTT vs USPS Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, USPS has a market cap of 181.1K. Regarding current trading prices, HLTT is priced at $0.00, while USPS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas USPS's P/E ratio is -1.14. In terms of profitability, HLTT's ROE is +1789941.38%, compared to USPS's ROE of -0.63%. Regarding short-term risk, HLTT and USPS have similar daily volatility (0.00).Check USPS's competition here
HLTT vs DSOL Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, DSOL has a market cap of 177.8K. Regarding current trading prices, HLTT is priced at $0.00, while DSOL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas DSOL's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to DSOL's ROE of +0.05%. Regarding short-term risk, HLTT and DSOL have similar daily volatility (0.00).Check DSOL's competition here
HLTT vs CGNSF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, CGNSF has a market cap of 170.2K. Regarding current trading prices, HLTT is priced at $0.00, while CGNSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas CGNSF's P/E ratio is -0.03. In terms of profitability, HLTT's ROE is +1789941.38%, compared to CGNSF's ROE of +0.96%. Regarding short-term risk, HLTT and CGNSF have similar daily volatility (0.00).Check CGNSF's competition here
HLTT vs ALDNF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ALDNF has a market cap of 160.4K. Regarding current trading prices, HLTT is priced at $0.00, while ALDNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ALDNF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ALDNF's ROE of +0.00%. Regarding short-term risk, HLTT and ALDNF have similar daily volatility (0.00).Check ALDNF's competition here
HLTT vs EMYSF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, EMYSF has a market cap of 151.7K. Regarding current trading prices, HLTT is priced at $0.00, while EMYSF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas EMYSF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to EMYSF's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to EMYSF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check EMYSF's competition here
HLTT vs PASO Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PASO has a market cap of 74.1K. Regarding current trading prices, HLTT is priced at $0.00, while PASO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PASO's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PASO's ROE of +6.20%. Regarding short-term risk, HLTT and PASO have similar daily volatility (0.00).Check PASO's competition here
HLTT vs REFG Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, REFG has a market cap of 60.8K. Regarding current trading prices, HLTT is priced at $0.00, while REFG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas REFG's P/E ratio is -0.01. In terms of profitability, HLTT's ROE is +1789941.38%, compared to REFG's ROE of +0.01%. Regarding short-term risk, HLTT and REFG have similar daily volatility (0.00).Check REFG's competition here
HLTT vs HDVY Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, HDVY has a market cap of 41.2K. Regarding current trading prices, HLTT is priced at $0.00, while HDVY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas HDVY's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to HDVY's ROE of +0.00%. Regarding short-term risk, HLTT and HDVY have similar daily volatility (0.00).Check HDVY's competition here
HLTT vs RVRC Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, RVRC has a market cap of 40.4K. Regarding current trading prices, HLTT is priced at $0.00, while RVRC trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas RVRC's P/E ratio is -0.11. In terms of profitability, HLTT's ROE is +1789941.38%, compared to RVRC's ROE of -0.29%. Regarding short-term risk, HLTT and RVRC have similar daily volatility (0.00).Check RVRC's competition here
HLTT vs IGRW Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, IGRW has a market cap of 39.8K. Regarding current trading prices, HLTT is priced at $0.00, while IGRW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas IGRW's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to IGRW's ROE of +7.88%. Regarding short-term risk, HLTT is less volatile compared to IGRW. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check IGRW's competition here
HLTT vs WMGR Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, WMGR has a market cap of 36.3K. Regarding current trading prices, HLTT is priced at $0.00, while WMGR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas WMGR's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to WMGR's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to WMGR. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check WMGR's competition here
HLTT vs SSYNF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, SSYNF has a market cap of 33.3K. Regarding current trading prices, HLTT is priced at $0.00, while SSYNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas SSYNF's P/E ratio is -0.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to SSYNF's ROE of N/A. Regarding short-term risk, HLTT and SSYNF have similar daily volatility (0.00).Check SSYNF's competition here
HLTT vs SOFE Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, SOFE has a market cap of 31K. Regarding current trading prices, HLTT is priced at $0.00, while SOFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas SOFE's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to SOFE's ROE of +0.52%. Regarding short-term risk, HLTT and SOFE have similar daily volatility (0.00).Check SOFE's competition here
HLTT vs TTBLF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, TTBLF has a market cap of 26.7K. Regarding current trading prices, HLTT is priced at $0.00, while TTBLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas TTBLF's P/E ratio is -0.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to TTBLF's ROE of -1.03%. Regarding short-term risk, HLTT is less volatile compared to TTBLF. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check TTBLF's competition here
HLTT vs NHEL Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, NHEL has a market cap of 16.2K. Regarding current trading prices, HLTT is priced at $0.00, while NHEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas NHEL's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to NHEL's ROE of +0.00%. Regarding short-term risk, HLTT and NHEL have similar daily volatility (0.00).Check NHEL's competition here
HLTT vs FDBH Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, FDBH has a market cap of 15K. Regarding current trading prices, HLTT is priced at $0.00, while FDBH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas FDBH's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to FDBH's ROE of +0.32%. Regarding short-term risk, HLTT and FDBH have similar daily volatility (0.00).Check FDBH's competition here
HLTT vs ORHB Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ORHB has a market cap of 12.8K. Regarding current trading prices, HLTT is priced at $0.00, while ORHB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ORHB's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ORHB's ROE of +0.33%. Regarding short-term risk, HLTT and ORHB have similar daily volatility (0.00).Check ORHB's competition here
HLTT vs PCYS Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, PCYS has a market cap of 11K. Regarding current trading prices, HLTT is priced at $0.00, while PCYS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas PCYS's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to PCYS's ROE of -2.71%. Regarding short-term risk, HLTT is less volatile compared to PCYS. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check PCYS's competition here
HLTT vs OLMM Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, OLMM has a market cap of 10.1K. Regarding current trading prices, HLTT is priced at $0.00, while OLMM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas OLMM's P/E ratio is -0.01. In terms of profitability, HLTT's ROE is +1789941.38%, compared to OLMM's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to OLMM. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check OLMM's competition here
HLTT vs MOSTQ Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, MOSTQ has a market cap of 8.5K. Regarding current trading prices, HLTT is priced at $0.00, while MOSTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas MOSTQ's P/E ratio is -0.00. In terms of profitability, HLTT's ROE is +1789941.38%, compared to MOSTQ's ROE of +2.26%. Regarding short-term risk, HLTT and MOSTQ have similar daily volatility (0.00).Check MOSTQ's competition here
HLTT vs APYI Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, APYI has a market cap of 8.5K. Regarding current trading prices, HLTT is priced at $0.00, while APYI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas APYI's P/E ratio is -0.71. In terms of profitability, HLTT's ROE is +1789941.38%, compared to APYI's ROE of -0.60%. Regarding short-term risk, HLTT is less volatile compared to APYI. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check APYI's competition here
HLTT vs ACNV Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ACNV has a market cap of 8.1K. Regarding current trading prices, HLTT is priced at $0.00, while ACNV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ACNV's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ACNV's ROE of +0.00%. Regarding short-term risk, HLTT and ACNV have similar daily volatility (0.00).Check ACNV's competition here
HLTT vs NMXS Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, NMXS has a market cap of 3.8K. Regarding current trading prices, HLTT is priced at $0.00, while NMXS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas NMXS's P/E ratio is -0.01. In terms of profitability, HLTT's ROE is +1789941.38%, compared to NMXS's ROE of +1.59%. Regarding short-term risk, HLTT and NMXS have similar daily volatility (0.00).Check NMXS's competition here
HLTT vs BBLNF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, BBLNF has a market cap of 2.6K. Regarding current trading prices, HLTT is priced at $0.00, while BBLNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas BBLNF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to BBLNF's ROE of +1.06%. Regarding short-term risk, HLTT and BBLNF have similar daily volatility (0.00).Check BBLNF's competition here
HLTT vs ETAOF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, ETAOF has a market cap of 1.5K. Regarding current trading prices, HLTT is priced at $0.00, while ETAOF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas ETAOF's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to ETAOF's ROE of -13.69%. Regarding short-term risk, HLTT and ETAOF have similar daily volatility (0.00).Check ETAOF's competition here
HLTT vs LGBI Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, LGBI has a market cap of 501. Regarding current trading prices, HLTT is priced at $0.00, while LGBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas LGBI's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to LGBI's ROE of +0.00%. Regarding short-term risk, HLTT is less volatile compared to LGBI. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check LGBI's competition here
HLTT vs WTEQF Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, WTEQF has a market cap of 0. Regarding current trading prices, HLTT is priced at $0.00, while WTEQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas WTEQF's P/E ratio is 1.78. In terms of profitability, HLTT's ROE is +1789941.38%, compared to WTEQF's ROE of N/A. Regarding short-term risk, HLTT and WTEQF have similar daily volatility (0.00).Check WTEQF's competition here
HLTT vs VMCS Comparison August 2025
HLTT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HLTT stands at 10.7K. In comparison, VMCS has a market cap of 0. Regarding current trading prices, HLTT is priced at $0.00, while VMCS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HLTT currently has a P/E ratio of N/A, whereas VMCS's P/E ratio is N/A. In terms of profitability, HLTT's ROE is +1789941.38%, compared to VMCS's ROE of +3.10%. Regarding short-term risk, HLTT is less volatile compared to VMCS. This indicates potentially lower risk in terms of short-term price fluctuations for HLTT.Check VMCS's competition here